Investors / United States / Old Line Capital Partners
Old Line Capital Partners
Venture capital · Bowie, MD, United States · North America
Old Line Capital Partners is an investment partnership that provides early stage funding to bring new products to market. It also offers mentoring, networking and small business expertise alongside its investment.
Invests inHealthcare & BiotechCybersecurity
In its own wordsearly stagemid-atlanticmarylandmentoring
Your fit with Old Line Capital Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsOld Line Capital Partners lists 10 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (21%), Cybersecurity (21%) and Fintech (14%). 100% of its companies are based in United States. It invests most often alongside TEDCO, BlueWing Ventures and Ferocity Capital.
No funding round on record names Old Line Capital Partners yet, so the figures come from its portfolio page.
Round figures show recent activity, not Old Line Capital Partners' whole history. Rounds on record name 0 companies; its own site lists 10. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 21% | 15% |
| Cybersecurity | 21% | 4% |
| Fintech | 14% | 12% |
| Food & Agriculture | 7% | 3% |
| Education | 7% | 7% |
| Media & Entertainment | 7% | 4% |
| Industrial & Manufacturing | 7% | 7% |
| Real Estate & Construction | 7% | 3% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| TEDCO | 2 |
| BlueWing Ventures | 1 |
| Ferocity Capital | 1 |
| MACH37 | 1 |
| NYBC Ventures | 1 |
| Naples Technology Ventures | 1 |
| Paladin Capital Group | 1 |
| Preccelerator Program | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 21th | 21% in its largest sector |
| Reach | 19th | 1 country |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers990%
- No longer answers00%
- Points to another company110%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare Old Line Capital Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| BreachBits provides a cyber risk radar platform that emulates attackers to deliver insights on cyber risk | CybersecurityFintech | Portfolio page | ||
| CarrTech develops and markets a medical device called FROG that combines a filter and hypodermic needle for preparing injectable medications. | Healthcare & Biotech | Portfolio page | ||
| Hushmesh develops a system called the Mesh, which enables autonomous agents to coordinate and transact as global economic actors | CybersecurityAI & Machine Learning | Portfolio page | ||
| Breakthru helps organizations launch branded digital communities and turn engagement into actionable insight for youth-focused organizations. | EducationMedia & Entertainment | Portfolio page | ||
| KaloCyte is developing ErythroMer, a dried, bio-inspired artificial red blood cell, to treat life-threatening blood loss when stored red blood cells are unavailable, undesirable or in short supply. | Healthcare & Biotech | Portfolio page | ||
| Liatris, Inc. produces high-performance insulation products for building construction. | Industrial & ManufacturingReal Estate & Construction | Portfolio page | ||
| Maspanadas produces and sells empanadas and other Latin-inspired food products. | Food & Agriculture | Portfolio page | ||
| Novel Microdevices develops a portable PCR system for molecular testing of certain infections | Healthcare & Biotech | Portfolio page | ||
FintechCybersecurity | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- oldlinecap.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Old Line Capital Partners' profile as data
Pull Old Line Capital Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/oldlinecap.com
# also
GET /v1/firms/oldlinecap.com/portfolio
GET /v1/firms/oldlinecap.com/coinvestors
GET /v1/firms/oldlinecap.com/news